Tag: Survival
Health Improves Over Two Years for COVID-19 Hospitalization Survivors
Improvements seen in physical and mental health, but survivors still have more symptoms than controls at two years
Cancer Survivors Face Transportation Barriers to Accessing Care
Survivors who are younger, poor, uninsured or publicly insured, unmarried, or who have functional limitations have greatest barriers
No Long-Term Advantage Seen for Off-Pump Versus On-Pump CABG
Time to all-cause death or repeated revascularization shorter with off-pump versus on-pump coronary artery bypass grafting
Outcomes Compared for Aortic Valve Replacement Options in Adults
Ross procedure associated with better long-term survival than biological and mechanical AVR in adults aged 18 to 50 years
Durable Remission Seen in Two CLL Patients After CAR T Cell Therapy
CAR T cells detectable more than 10 years after infusion with sustained remission in both patients
Survival High With Lung Transplant for COVID-19-Associated ARDS
No patients demonstrated antibody-mediated rejection; all recipients alive at follow-up
Prevalence of Chronic Conditions Increased Among Cancer Survivors
Increase also seen in prevalence of multiple chronic conditions for cancer survivors, which was most pronounced among those aged 18 to 44 years
Combo Immunotherapy Ups Survival in Advanced Liver Cancer
Overall survival, but not progression-free survival, improved with tremelimumab plus durvalumab versus sorafenib for unresectable HCC
Adding Immunotherapy to Chemo Ups Survival in Advanced Biliary Tract Cancer
Overall survival, progression-free survival prolonged in those receiving durvalumab versus placebo in addition to gemcitabine and cisplatin
Long-Term Outcomes Described for Survivors of Childhood ALL
Life challenges more negatively impacted in younger, female, relapsed patients; socializing more positively impacted in older patients
